PuSH - Publication Server of Helmholtz Zentrum München: Mutation detection in patients with retinal dystrophies using targeted next generation sequencing.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Weisschuh, N.* ; Mayer, A.K.* ; Strom, T.M. ; Kohl, S.* ; Glöckle, N.* ; Schubach, M.* ; Andreasson, S.* ; Bernd, A.* ; Birch, D.G.* ; Hamel, C.P.* ; Heckenlively, J.R.* ; Jacobson, S.G.* ; Kamme, C.* ; Kellner, U.* ; Kunstmann, E.* ; Maffei, P.* ; Reiff, C.M.* ; Rohrschneider, K.* ; Rosenberg, T.* ; Rudolph, G.* ; Vámos, R.* ; Varsányi, B.* ; Weleber, R.G.* ; Wissinger, B.*

Mutation detection in patients with retinal dystrophies using targeted next generation sequencing.

PLoS ONE 11:e0145951 (2016)

Publ. Version/Full Text

DOI

PMC

	Open Access Gold

Abstract
Metrics
Extra information

Retinal dystrophies (RD) constitute a group of blinding diseases that are characterized by clinical variability and pronounced genetic heterogeneity. The different nonsyndromic and syndromic forms of RD can be attributed to mutations in more than 200 genes. Consequently, next generation sequencing (NGS) technologies are among the most promising approaches to identify mutations in RD. We screened a large cohort of patients comprising 89 independent cases and families with various subforms of RD applying different NGS platforms. While mutation screening in 50 cases was performed using a RD gene capture panel, 47 cases were analyzed using whole exome sequencing. One family was analyzed using whole genome sequencing. A detection rate of 61% was achieved including mutations in 34 known and two novel RD genes. A total of 69 distinct mutations were identified, including 39 novel mutations. Notably, genetic findings in several families were not consistent with the initial clinical diagnosis. Clinical reassessment resulted in refinement of the clinical diagnosis in some of these families and confirmed the broad clinical spectrum associated with mutations in RD genes.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

3.057

1.034